Literature DB >> 12727954

Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

Patricia Iozzo1, Kirsti Hallsten, Vesa Oikonen, Kirsi A Virtanen, Jukka Kemppainen, Olof Solin, Ele Ferrannini, Juhani Knuuti, Pirjo Nuutila.   

Abstract

Impaired hepatic glucose uptake (HGU) has been implicated in the development of hyperglycemia in type 2 diabetes; the relative impact of plasma glucose and insulin levels on this process remains controversial. We compared the effects of euglycemic hyperinsulinemia on HGU, skeletal muscle glucose uptake, and hepatic influx rate-constant (H-Ki) in 38 diet-treated diabetic patients and 22 nondiabetic controls, using positron emission tomography with (18)F-fluorodeoxyglucose and the insulin clamp technique. Control subjects were divided into two subgroups: one including older, heavier, insulin-resistant controls (whole-body glucose uptake, M = 21.4 +/- 5.4 micromol x min(-1) x kg(-1)) to match characteristics of diabetic patients (M = 20.4 +/- 9.9); the other including younger, leaner, insulin-sensitive controls (M = 48.2 +/- 9.9, P < 0.01). Skeletal muscle glucose uptake showed a similar group distribution as the M value. Insulin clearance rates were lower, whereas glycosylated hemoglobin and clamp plasma insulin levels were higher in diabetic patients than in controls. HGU and H-Ki were similar in the two nondiabetic subgroups and lower in diabetic patients than in controls (1.9 +/- 0.5 vs. 2.3 +/- 0.7 micromol x min(-1) x 100 ml(-1), and 0.37 +/- 0.09 vs. 0.44 +/- 0.14 ml x min(-1) x 100 ml(-1), P < or = 0.01). In the whole dataset, H-Ki was inversely related to fasting plasma glucose (correlation coefficient = -0.40, P = 0.0018). In diabetic subjects, H-Ki was reciprocally related to glycosylated hemoglobin (correlation coefficient = -0.36, P = 0.029). We conclude that insulin-mediated HGU is impaired, in type 2 diabetes, in some proportion to the degree of glycemic control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727954     DOI: 10.1210/jc.2002-021446

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.

Authors:  P Iozzo; R Lautamaki; F Geisler; K A Virtanen; V Oikonen; M Haaparanta; H Yki-Jarvinen; E Ferrannini; J Knuuti; P Nuutila
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

2.  Metabolic Surgery Could Restore Hepatic Glucose Metabolism: Results from F-18 Fluorodeoxyglucose Positron Emission Tomography.

Authors:  Yeongkeun Kwon; Kisoo Pahk; Sungsoo Park; Raul J Rosenthal
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

3.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

4.  Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.

Authors:  Markus M Lindroos; Ronald Borra; Nina Mononen; Terho Lehtimäki; Kirsi A Virtanen; Virva Lepomäki; Letizia Guiducci; Patricia Iozzo; Kari Majamaa; Pirjo Nuutila
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

5.  Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial.

Authors:  Kumail K Motiani; Anna M Savolainen; Jussi Toivanen; Jari-Joonas Eskelinen; Minna Yli-Karjanmaa; Kirsi A Virtanen; Virva Saunavaara; Marja A Heiskanen; Riitta Parkkola; Merja Haaparanta-Solin; Olof Solin; Nina Savisto; Eliisa Löyttyniemi; Juhani Knuuti; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  J Appl Physiol (1985)       Date:  2019-04-18

6.  A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects.

Authors:  O Vahidi; K E Kwok; R B Gopaluni; F K Knop
Journal:  Med Biol Eng Comput       Date:  2015-10-22       Impact factor: 2.602

7.  Hepato-splenic axis: hepatic and splenic metabolic activities are linked.

Authors:  Georgia Keramida; Alexander Dunford; Guven Kaya; Constantinos D Anagnostopoulos; Adrien Michael Peters
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

8.  Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions.

Authors:  N Kudomi; M J Järvisalo; J Kiss; R Borra; A Viljanen; T Viljanen; T Savunen; J Knuuti; H Iida; P Nuutila; P Iozzo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

9.  Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

10.  Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Yuka Fujimoto; E P Donahue; Richard L Printz; Karen L Houseknecht; Judith L Treadway; Masakazu Shiota
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.